Track topics on Twitter Track topics that are important to you
Cellestis was formed in late 2000 to research, develop and market QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune (CMI) responses using whole blood samples. This unique technology provides its users savings in time, labor and reagents compared to other methodologies of measuring CMI
28043 Smyth Drive
United States of America
To assess whether children ≤5 years of age, produce sufficient amounts of interferon gamma (IFN-ɣ) in response to phytohaemagglutinin (mitogen), and Mycobacterium tuberculosis antigens (TB antigens...
The aim of this project is to analyze the potential contribution of IGRA test QuantiFERON-TB Gold In Tube test (QTF-GIT, Cellestis Limited, Carnegie, Victoria, Australia) in the diagnosis ...
Cellestis was formed in late 2000 to research, develop and market QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood me...
We have published hundreds of Cellestis Inc news stories on BioPortfolio along with dozens of Cellestis Inc Clinical Trials and PubMed Articles about Cellestis Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cellestis Inc Companies in our database. You can also find out about relevant Cellestis Inc Drugs and Medications on this site too.